“…Various manifestations of positional analogue scanning have been reported in the literature for decades, variably described as an atom or substituent scan, transposition, shift, walk, dance, or shuffle, generally constituting a partial scan of a single aromatic or heteroaromatic ring of a polycyclic drug molecule, and typically focused on a single pharmacological parameter, such as potency. , It is recommended in this Perspective that a generic term, positional analogue scanning, be used to describe this general strategy, as positional analogue scanning in small molecule drug discovery is analogous to alanine scanning in polypeptide biochemical studies and both are intended to be systematic and complete. , The maximal value of positional analogue scanning can be realized by assessment of negative, neutral, or positive impacts across multiple pharmacological parameters, exploring all possible positional analogues in situations where predictive modeling is not available. , Additionally, positional analogue scanning can provide opportunities to identify activity cliffs and nonadditive SAR that may elucidate ligand binding conformations and receptor binding modes . The modern need in chemical biology and drug discovery for rapid and simultaneous multiparameter optimization justifies the synthesis investment that may be required to enable full positional analogue scanning.…”